EJCTS Click here for details of sales representative
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Pierre Corbi
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Corbi, P.
Right arrow Articles by Lecron, J.-C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Corbi, P.
Right arrow Articles by Lecron, J.-C.

Eur J Cardiothorac Surg 2000;18:98-103
© 2000 Elsevier Science NL


Circulating soluble gp130, soluble IL-6R, and IL-6 in patients undergoing cardiac surgery, with or without extracorporeal circulation

Pierre Corbia, Mohammad Rahmatia, Adriana Delwailb, Daniel Potreauc, Paul Menua, John Wijdenesd, Jean-Claude Lecronb

a Cardio-thoracic Surgery Unit, Poitiers Hospital, Poitiers, France
b Cytokine group, ESA CNRS 6031, IBMIG, Université de Poitiers, 40 Avenue du Recteur Pineau, 86022 Poitiers Cedex, France
c UMR CNRS 6558, Université de Poitiers, Poitiers, France
d DIACLONE Laboratory, Besançon, France

Received 7 October 1999; received in revised form 4 February 2000; accepted 9 February 2000.

Corresponding author. Tel.: +33-5-4945-4057; fax: +33-5-4945-3503
e-mail: jean-claude.lecron{at}campus.univ-poitiers.fr

Objective: Soluble forms of interleukin-6 (IL-6) receptors are known to modulate biological activities of IL-6. The purpose of the study was to measure circulating levels of IL-6, sIL-6R and sgp130 in patients undergoing coronary artery bypass grafting with cardiopulmonary bypass (CPB group) or without CPB (non-CPB group). Methods: The CPB group included 19 patients and the non-CPB group 12 patients. Sera levels of IL-6, sIL-6R and sgp130 were measured by specific ELISA at the beginning of the operation (T0, 15 min before skin incision) and 6 h later (T1). Results: IL-6 sera levels were respectively 9±20 pg/ml (mean±SD) and 13±19 pg/ml at T0 and reached 340±250 pg/ml and 965±1060 pg/ml at T1 in CPB and non-CPB groups, indicating a significant increase from T0 to T1, but no differences between the two groups. When compared to T0 values, sgp130 levels decreased in both groups (respectively 105±37 and 115±35 ng/ml at T0 for CPB and non-CPB groups, and 72±25 and 84±29 ng/ml at T1) while we are not able to detect differences between the groups. Whatever the group or the time, sIL-6R concentrations remained unchanged. Conclusions: We showed that the increase of IL-6 after artery bypass grafting was similar between patients operated with CPB or without CPB. We conclude that the main inductor of IL-6 release is linked to surgical trauma rather than a reaction to CPB. Since it is known that gp130 inhibits IL-6-biological activities, we suggest that the decrease of sgp130 sera levels could further enhance the inflammatory effects of IL-6 in cardiac surgery.

Key Words: Interleukin-6 • sIL-6R • sgp130 • Cardiopulmonary bypass • Cardiac surgery




This article has been cited by other articles:


Home page
PerfusionHome page
G. Brancaccio, E. Villa, E. Girolami, G. Michielon, C. Feltri, E. Mazzera, D. Costa, G. Isacchi, E. Iannace, A. Amodeo, et al.
Inflammatory cytokines in pediatric cardiac surgery and variable effect of the hemofiltration process
Perfusion, September 1, 2005; 20(5): 263 - 268.
[Abstract] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
J. G. Coles, C. Boscarino, M. Takahashi, D. Grant, A. Chang, J. Ritter, X. Dai, C. Du, G. Musso, H. Yamabi, et al.
Cardioprotective stress response in the human fetal heart
J. Thorac. Cardiovasc. Surg., May 1, 2005; 129(5): 1128 - 1136.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
P. Biglioli, A. Cannata, F. Alamanni, M. Naliato, M. Porqueddu, M. Zanobini, E. Tremoli, and A. Parolari
Biological effects of off-pump vs. on-pump coronary artery surgery: focus on inflammation, hemostasis and oxidative stress
Eur. J. Cardiothorac. Surg., August 1, 2003; 24(2): 260 - 269.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
C. Ancey, E. Menet, P. Corbi, S. Fredj, M. Garcia, C. Rucker-Martin, J. Bescond, F. Morel, J. Wijdenes, J.-C. Lecron, et al.
Human cardiomyocyte hypertrophy induced in vitro by gp130 stimulation
Cardiovasc Res, July 1, 2003; 59(1): 78 - 85.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
M. Caputo, M. Yeatman, P. Narayan, G. Marchetto, R. Ascione, B. C. Reeves, and G. D. Angelini
Effect of off-pump coronary surgery with right ventricular assist device on organ function and inflammatory response: a randomized controlled trial
Ann. Thorac. Surg., December 1, 2002; 74(6): 2088 - 2095.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
D J Brull, J Sanders, A Rumley, G D Lowe, S E Humphries, and H E Montgomery
Impact of angiotensin converting enzyme inhibition on post-coronary artery bypass interleukin 6 release
Heart, March 1, 2002; 87(3): 252 - 255.
[Abstract] [Full Text] [PDF]


Home page
PerfusionHome page
C. R Holleyman and D. F Larson
Apoptosis in the ischemic reperfused myocardium
Perfusion, December 1, 2001; 16(6): 491 - 502.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
P. Menasche
The systemic factor: the comparative roles of cardiopulmonary bypass and off-pump surgery in the genesis of patient injury during and following cardiac surgery
Ann. Thorac. Surg., December 1, 2001; 72(6): S2260 - 2265.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
P. J. Corbi, M. Rahmati, and J.-C. Lecron
Inflammatory response associated with cardiopulmonary bypass and effect of methylprednisolone
J. Thorac. Cardiovasc. Surg., November 1, 2001; 122(5): 1052 - 1052.
[Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
D.J. Brull, H.E. Montgomery, J. Sanders, S. Dhamrait, L. Luong, A. Rumley, G.D.O. Lowe, and S.E. Humphries
Interleukin-6 Gene -174G>C and -572G>C Promoter Polymorphisms Are Strong Predictors of Plasma Interleukin-6 Levels After Coronary Artery Bypass Surgery
Arterioscler Thromb Vasc Biol, September 1, 2001; 21(9): 1458 - 1463.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2000 European Association for Cardio-Thoracic Surgery. Published by Elsevier. All rights reserved.